Third Rock Ventures V, L.P.

10% owner, Rapport Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$6.1M

Companies

Latest trade

May 26, 2026

Companies

Rapport Therapeutics, Inc.10% owner −$6.1M

Trades

RAPP Sold 18,572 shares at $40.05 · planned $0.7M May 26

RAPP Sold 133,618 shares at $40.24 · planned $5.4M May 11

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.